万邦医药: 第二届监事会第十二次会议决议公告

Group 1 - The company held its 12th meeting of the second Supervisory Board on May 13, 2025, with all three supervisors present, confirming compliance with relevant laws and regulations [1][2] - The Supervisory Board approved the proposal for the initial grant of restricted stock under the 2025 incentive plan, confirming that the conditions for granting and the eligibility of the incentive objects were met [1][2] - A total of 509,375 restricted shares will be granted to 88 incentive objects at a price of 19.75 yuan per share, with the grant date set as May 13, 2025 [2]